Acadia Pharmaceuticals reported $-43000000 in Net Income for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -43M 46M
Adamas Pharmaceuticals ADMS:US $ 19276M 29M
Alexion Pharmaceuticals ALXN:US $ -1068.1M 1625.7M
Alnylam Pharmaceuticals ALNY:US $ -253.29M 74.06M
Biogen BIIB:US $ 701.5M 840.6M
Biomarin Pharmaceutical BMRN:US $ -29.18M 110.56M
Bristol Myers Squibb BMY:US $ -85M 690M
Corcept Therapeutics CORT:US $ 28M 2M
Cytokinetics CYTK:US $ -3.18M 37.6M
Eisai 4523:JP Y 24425M 24092M
Eli Lilly And LLY:US $ 1412M 44.5M
Gw Pharmaceuticals GWPH:US $ -12.19M 3.36M
Intercept Pharmaceuticals ICPT:US $ -63.28M 29.7M
Johnson & Johnson JNJ:US $ 3554M 72M
Neurocrine Biosciences NBIX:US $ 79M 42M
Pfizer PFE:US $ 3426M 25M
Prothena PRTA:US $ -30.58M 4.3M
Ptc Therapeutics PTCT:US $ -181.43M 68.74M
Sarepta Therapeutics SRPT:US $ -151M 133M
Seattle Genetics SGEN:US $ 636.17M 657.36M
Ultragenyx Pharmaceutical RARE:US $ 25.32M 144.34M
Vanda Pharmaceuticals VNDA:US $ 8.71M 8.23M
Vertex Pharmaceuticals VRTX:US $ 837.27M 234.52M
YTE INCY:US $ 290.3M 1010.94M
Zogenix ZGNX:US $ -54M 28M